📰 Oncoextra Test News
Oncoextra Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Oncoextra Test. Real-time updates on events, politics, business and more.
June 4, 2024
Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
June 1, 2024
TFO Wealth Partners LLC raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 76,466.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,594 shares of the medical research company’s stock after acquiring an additional 4,588 shares during the […]
May 27, 2024
1492 Capital Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 84,154 shares of the medical research company’s stock after selling 362 shares during […]
May 26, 2024
Johnson Financial Group Inc. boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1,637.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,299 shares of the medical research company’s stock after buying an additional 4,994 shares during […]
April 27, 2024
Abrdn plc grew its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 48.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,106 shares of the medical research company’s stock after purchasing an additional 34,494 shares during the period. abrdn plc […]
April 27, 2024
Motley Fool Asset Management LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. Motley […]
April 27, 2024
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]
April 26, 2024
Xponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,405 shares of the medical research company’s stock after selling 668 shares during the […]
April 21, 2024
Hussman Strategic Advisors Inc. grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 400.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,500 shares of the medical research company’s stock after buying an additional 25,200 shares […]
April 18, 2024
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 16,937 call options on the company. This is an increase of 291% compared to the average volume of 4,328 call options. Insider Activity at Exact Sciences In other Exact Sciences news, CEO Kevin T. […]